Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability
published in: Human Molecular Genetics
date of publication: 2001-08-01
main subject: 4-fumarylacetoacetate(2-)
Bibliographic databases:
Cites articles
There is nothing here
Article -